Anzeige
Mehr »
Montag, 13.10.2025 - Börsentäglich über 12.000 News
Der Mann, der ein Lithium-Unternehmen im Wert von 1,2 Milliarden Dollar aufgebaut hat, ist zurück...
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EGXK | ISIN: SE0020353928 | Ticker-Symbol: MB8
Tradegate
08.10.25 | 12:57
0,773 Euro
+5,17 % +0,038
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
MOBERG PHARMA AB Chart 1 Jahr
5-Tage-Chart
MOBERG PHARMA AB 5-Tage-Chart
RealtimeGeldBriefZeit
0,7230,77120:14
0,7360,75820:13

Aktuelle News zur MOBERG PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
29.09.Moberg Pharma AB: Bulletin from Moberg Pharma's Extraordinary General Meeting held on 29 September 202593STOCKHOLM, September 29th, 2025. Moberg Pharma AB (publ) ("Moberg Pharma" or the "Company") today held an Extraordinary General Meeting. The Extraordinary General Meeting resolved in accordance with...
► Artikel lesen
03.09.Notice of extraordinary general meeting in Moberg Pharma AB (publ)1
03.09.Moberg Pharma to Expand Board of Directors and Withdraw Share Issue Authorization1
12.08.Moberg Pharma AB: Interim report January - June 2025137TERCLARA MARKET LEADER ALSO IN NORWAY SIX-MONTH PERIOD (JAN-JUN 2025) • Net revenue SEK 7.5 million (4.9) • EBITDA SEK -13.1 million (-12.7) • Operating profit (EBIT) SEK -13.9 million (-13.4)...
► Artikel lesen
30.06.New number of shares and votes in Moberg Pharma AB (publ)1
MOBERG PHARMA Aktie jetzt für 0€ handeln
25.06.Changes to Moberg Pharma's Management10
16.06.MOBERG PHARMA AB: Terclara market leader also in Norway1
03.06.MOBERG PHARMA AB: The board of directors exercises authorizations to issue and repurchase C-shares, and converts class C shares to common shares1
22.05.Bulletin from Moberg Pharma's AGM on May 22[th], 20253
13.05.Moberg Pharma AB: Moberg Pharma interim report January - March 2025130TERCLARA NOW ALSO AVAILABLE IN NORWAY FIRST QUARTER (JAN-MAR 2025) Net revenue SEK 3.9 million (0.8) EBITDA SEK -3.7 million (-7.6) Operating profit (EBIT) SEK -4.1 million (-7.9) Profit for...
► Artikel lesen
22.04.Notice of Annual General Meeting in Moberg Pharma AB (publ)1
11.02.Moberg Pharma AB: Moberg Pharma Year-end report 2024248TERCLARA CONTINUES TO LEAD THE MARKET AND EXPANDS TO NORWAY THE YEAR (JAN-DEC 2024) Net revenue SEK 9.8 million (0) EBITDA SEK -23.5 million (-25.4) Operating profit (EBIT) SEK -324.8 million...
► Artikel lesen
10.12.24Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU229STOCKHOLM, Dec. 10, 2024 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) announces that MOB-015 (topical terbinafine) did not meet the primary endpoint in the phase...
► Artikel lesen
12.11.24Moberg Pharma AB: Moberg Pharma's Interim report January - September 2024214TERCLARA WINS LAUNCH OF THE YEAR AT KRONANS PHARMACY AND DOZ PHARMACY NINE-MONTH PERIOD (JAN-SEP 2024) Net income SEK 8.8 million (0) EBITDA SEK -15.7 million (-17.4) Operating profit (EBIT) SEK...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1